Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 1, Pages 316
Publisher
MDPI AG
Online
2021-12-29
DOI
10.3390/ijms23010316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intracellular immune sensing promotes inflammation via gasdermin D–driven release of a lectin alarmin
- (2021) Ashley J. Russo et al. NATURE IMMUNOLOGY
- Reprogramming the tumor metastasis cascade by targeting galectin-driven networks
- (2021) Ramiro M. Perrotta et al. BIOCHEMICAL JOURNAL
- Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
- (2021) Riyao Yang et al. Nature Communications
- The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
- (2021) Vincenzo Mattei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells
- (2021) Alejandro J. Cagnoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- Fluorescence-Guided Surgery in the Surgical Treatment of Gliomas: Past, Present and Future
- (2021) Rosa Sun et al. Cancers
- Autophagy Drives Galectin-1 Secretion From Tumor-Associated Macrophages Facilitating Hepatocellular Carcinoma Progression
- (2021) Goutham Venkata Naga Davuluri et al. Frontiers in Cell and Developmental Biology
- Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
- (2021) Yanyu Huang et al. Biomolecules
- Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
- (2021) Laetitia Seguin et al. Communications Biology
- Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins
- (2021) Aaftaab Sethi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
- (2020) Patrick Y Wen et al. NEURO-ONCOLOGY
- Management of glioblastoma: State of the art and future directions
- (2020) Aaron C. Tan et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of Galectins in Resistance to Anticancer Therapies
- (2020) Pilar Navarro et al. CLINICAL CANCER RESEARCH
- Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities
- (2020) Juan M. Pérez Sáez et al. ANGIOGENESIS
- Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
- (2020) Mengjia Song et al. BRITISH JOURNAL OF CANCER
- Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity
- (2020) Ming Wang et al. Cell Death & Disease
- The presence of TIM‐3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status
- (2020) Mia D. Sørensen et al. BRAIN PATHOLOGY
- Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors
- (2020) Isobel Okoye et al. Journal for ImmunoTherapy of Cancer
- NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
- (2020) Yuekun Wang et al. Frontiers in Oncology
- Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma
- (2019) Qun Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Exploitation of glycosylation in enveloped virus pathobiology
- (2019) Yasunori Watanabe et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Overlapping migratory mechanisms between neural progenitor cells and brain tumor stem cells
- (2019) Natanael Zarco et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme
- (2019) Yasuo Takashima et al. PLoS One
- Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma
- (2019) Xing Rong Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples
- (2019) Feng Yuan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
- (2019) Dhanya K. Nambiar et al. JOURNAL OF CLINICAL INVESTIGATION
- Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
- (2019) María Romina Girotti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
- (2018) Shang-Yu Chou et al. BMC CANCER
- SnapShot: O-Glycosylation Pathways across Kingdoms
- (2018) Hiren J. Joshi et al. CELL
- Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
- (2018) María T. Elola et al. CELLULAR IMMUNOLOGY
- Role of Galectins in Tumors and in Clinical Immunotherapy
- (2018) Feng-Cheng Chou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
- (2018) Shaofei Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
- (2018) Carlos A. Orozco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unconventional secretion of annexins and galectins
- (2018) Stephanie J. Popa et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Clinical Trials and Applications of Galectin Antagonists
- (2018) Armand Girard et al. TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY
- Untangling Galectin-Driven Regulatory Circuits in Autoimmune Inflammation
- (2018) Marta A. Toscano et al. TRENDS IN MOLECULAR MEDICINE
- LGALS3 promotes treatment resistance in glioblastoma and is associated with tumor risk and prognosis
- (2018) Hongxiang Wang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Single vs. combination immunotherapeutic strategies for glioma
- (2017) Mayuri Chandran et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- Translating the ‘Sugar Code’ into Immune and Vascular Signaling Programs
- (2017) Juan P. Cerliani et al. TRENDS IN BIOCHEMICAL SCIENCES
- Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells
- (2017) KeeSoo Nam et al. Oncotarget
- Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation
- (2017) Sofia Nascimento dos Santos et al. Oncotarget
- The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
- (2017) Isabel Gonçalves Silva et al. EBioMedicine
- Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
- (2017) Matthias Van Woensel et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways
- (2016) Gabriel A. Rabinovich et al. JOURNAL OF MOLECULAR BIOLOGY
- Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation
- (2016) Guoqing Cai et al. TUMOR BIOLOGY
- Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma
- (2016) ZENGJIN LIU et al. Oncology Letters
- Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells
- (2016) Wu Luo et al. Oncotarget
- Natural killer cells require monocytic Gr-1+/CD11b+ myeloid cells to eradicate orthotopically engrafted glioma cells
- (2016) Gregory J. Baker et al. OncoImmunology
- Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
- (2016) Alejandro J. Cagnoni et al. Frontiers in Oncology
- Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma
- (2016) Yu-Chi Su et al. PLoS One
- Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation
- (2015) Melanie R. Rutkowski et al. CANCER CELL
- Mechanisms regulating glioma invasion
- (2015) Ivy Paw et al. CANCER LETTERS
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
- (2015) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Galectin-1 Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells
- (2015) María L. Bacigalupo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Brain tumour cells interconnect to a functional and resistant network
- (2015) Matthias Osswald et al. NATURE
- Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
- (2015) Chiao-Wen Kang et al. Scientific Reports
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression
- (2015) Marie Le Mercier et al. NEOPLASIA
- Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
- (2014) Andrée-Anne Grosset et al. BMC CANCER
- International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
- (2014) David N. Louis et al. BRAIN PATHOLOGY
- Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010
- (2014) Haley R. Gittleman et al. CANCER
- Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
- (2014) G. J. Baker et al. CANCER RESEARCH
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Dedifferentiation and reprogramming: origins of cancer stem cells
- (2014) D. Friedmann-Morvinski et al. EMBO REPORTS
- Galectin-3 in angiogenesis and metastasis
- (2014) T. Funasaka et al. GLYCOBIOLOGY
- Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
- (2014) Chuan Wu et al. IMMUNITY
- Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer
- (2014) Soo-Jeong Cho et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- A neurocentric perspective on glioma invasion
- (2014) Vishnu Anand Cuddapah et al. NATURE REVIEWS NEUROSCIENCE
- Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
- (2014) Rafael Yamashita Ikemori et al. PLoS One
- Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
- (2014) P Zhang et al. Cell Death & Disease
- Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors
- (2013) Weizhen Jia et al. AMERICAN JOURNAL OF PATHOLOGY
- Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
- (2013) Tina Verschuere et al. INTERNATIONAL JOURNAL OF CANCER
- Brain tumor stem cells: Molecular characteristics and their impact on therapy
- (2013) David L. Schonberg et al. MOLECULAR ASPECTS OF MEDICINE
- Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination
- (2013) H.C. Hoyos et al. NEUROBIOLOGY OF DISEASE
- VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
- (2013) Nicky D'Haene et al. PLoS One
- Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
- (2012) F. Cedeno-Laurent et al. BLOOD
- A Galectin-3-Dependent Pathway Upregulates Interleukin-6 in the Microenvironment of Human Neuroblastoma
- (2012) A. M. Silverman et al. CANCER RESEARCH
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
- (2012) D. J. Laderach et al. CANCER RESEARCH
- Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
- (2012) Gabriel A. Rabinovich et al. IMMUNITY
- Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration
- (2012) Sarah C. Starossom et al. IMMUNITY
- Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
- (2012) Diego O. Croci et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
- (2012) Valerie R. Wiersma et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Galectin-3 in preneoplastic lesions of glioma
- (2012) Nguyen Huy Binh et al. JOURNAL OF NEURO-ONCOLOGY
- The good, the bad and the ugly: Epigenetic mechanisms in glioblastoma
- (2012) Helena Carén et al. MOLECULAR ASPECTS OF MEDICINE
- Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion
- (2012) L Toussaint et al. Molecular Cancer
- Inhibition of angiogenesis and the angiogenesis/invasion shift
- (2011) Andreas Bikfalvi et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
- (2011) Santiago Di Lella et al. BIOCHEMISTRY
- Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells
- (2011) N Mazurek et al. CELL DEATH AND DIFFERENTIATION
- Mechanisms and principles of N-linked protein glycosylation
- (2011) Flavio Schwarz et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Transdifferentiation of glioblastoma cells into vascular endothelial cells
- (2011) Y. Soda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8
- (2010) Víctor M. Cárdenas Delgado et al. FASEB JOURNAL
- Maintenance of cell surface glycan density by lectin-glycan interactions: A homeostatic and innate immune regulatory mechanism
- (2010) T. K. Dam et al. GLYCOBIOLOGY
- Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
- (2010) T Kobayashi et al. LEUKEMIA
- Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
- (2010) J. Kuroda et al. MOLECULAR CANCER RESEARCH
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
- (2010) Ruman Rahman et al. Journal of Oncology
- Galectins and Gliomas
- (2009) Marie Le Mercier et al. BRAIN PATHOLOGY
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses
- (2009) Marie Le Mercier et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
- (2009) Juan M Ilarregui et al. NATURE IMMUNOLOGY
- Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras
- (2008) Ruby Shalom-Feuerstein et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Galectin-1 Is Implicated in the Protein Kinase C ε/Vimentin-Controlled Trafficking of Integrin-β1 in Glioblastoma Cells
- (2008) Shannon Fortin et al. BRAIN PATHOLOGY
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices
- (2008) A. Nobumoto et al. GLYCOBIOLOGY
- Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes
- (2008) Nathalie Demotte et al. IMMUNITY
- Evidence of galectin-1 involvement in glioma chemoresistance☆
- (2008) Marie Le Mercier et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search